Mr Ravi Barod

Professional Biography

Additional Information

COVID-19 Specific Projects / Groups

Ravi Barod was involved in developing national guidance on prioritisation of kidney cancer surgery during the COVID-19 pandemic and he has published widely on this topic.

Awards

• The Tamaroff Fellowship. Full funding for 2nd year of fellowship at Vattikuti Urology Institute, Detroit, USA, 2015.
• Journal of Clinical Urology Prize for Best Poster of BAUS 2015 Annual Meeting
• The Urology Foundation Robotic Surgery Fellowship. To fund fellowship at Vattikuti Urology Institute, Detroit, USA, 2014.
• Royal Society of Medicine Ellison-Cliffe Travelling Fellowship. To fund fellowship at Vattikuti Urology Institute, Detroit, USA, 2014.
• British Journal of Urology International Prize for Best Presentation at SURG 2009.
• Royal Society of Medicine Oncology Section Sylvia Lawler Prize, 2009.
• Best Poster in Kidney Cancer, BAUS Glasgow, 2009.
• Royal Society of Medicine Urology Section Geoffrey Chisholm Prize, 2009.
• Best Poster in Session, American Urological Association, Chicago, 2009.
• Best Poster in Session, European Association of Urology, Stockholm, 2009.
• British Urological Foundation BAUS Scholarship. To fund final year of PhD, 2007.
• Royal College of Surgeons of England Research Fellowship. To fund final year of PhD, 2007.
• Royal Society of Medicine Urology Section Short Papers Prize, 2006.
• Kidney Research UK & Royal College of Surgeons of England Research Fellowship. To fund first 2 years of PhD, 2005.

Memberships

• National Cancer Research Institute Renal Cancer Subgroup
• British Association of Urological Surgeons
• European Association of Urology
• American Urological Association

Training Positions

Ravi Barod is an educational supervisor to senior fellows at The Specialist Centre for Kidney Cancer at The Royal Free Hospital. He specialises in training others using the innovative Da Vinci Robotic Surgical System that he uses in his practice.

This fellowship is accredited by The Royal College of Surgeons of England, The British Association of Urological Surgeons and The European Association of Urology Robotic Urology Section.

He has been involved in training surgeons on novel robotic techniques such as robotic kidney transplantation, and he has been invited to perform live surgery internationally.

Publications

Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: Implications for prioritization during the COVID-19 pandemic.

Tan WS, Marchese M, Paciotti M, Nguyen DD, Cone EB, Mossanen M, Webster JJ, Barod R, Bex A, Kibel AS, Chang SL, Trinh QD.Minerva Urol Nephrol. 2021 Mar 29. doi: 10.23736/S2724-6051.20.04197-1. PMID: 33781018

Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes.

Tan WS, Arianayagam R, Khetrapal P, Rowe E, Kearley S, Mahrous A, Pal R, Fowler W, Heer R, Elajnaf M, Douglas-Moore J, Leyshon Griffiths TR, Voss J, Wilby D, Al Kadhi O, Noel J, Vasdev N, McKay A, Ahmad I, Abu-Nayla I, Lamb B, Hill GT, Narahari K, Kynaston H, Yousuf A, Kusuma VRM, Cresswell J, Cooke P, Chakravarti A, Barod R, Bex A, Kelly JD; a multicentre collaborator group. Eur Urol Open Sci. 2021 Mar;25:39-43. doi: 10.1016/j.euros.2021.01.005. Epub 2021 Jan 9. PMID: 33458711

How does COVID-19 impact treatment decision-making for clinicians in localised kidney cancer.

Beyer K, Van Hemelrijck M, Kinsella N, Barod R. BJUI Compass. 2020 Nov 23:10.1002/bco2.57. doi: 10.1002/bco2.57. Online ahead of print.PMID: 33363288

A cohort study of 30 day mortality after NON-EMERGENCY surgery in a COVID-19 cold site.

Kasivisvanathan V, Lindsay J, Rakshani-Moghadam S, Elhamshary A, Kapriniotis K, Kazantzis G, Syed B, Hines J, Bex A, Ho DH, Hayward M, Bhan C, MacDonald N, Clarke S, Walker D, Bellingan G, Moore J, Rohn J, Muneer A, Roberts L, Haddad F, Kelly JD; UCLH study group collaborators. Int J Surg. 2020 Dec;84:57-65. doi: 10.1016/j.ijsu.2020.10.019. Epub 2020 Oct 24. PMID: 33122153

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

Glasbey JC, Nepogodiev D, Simoes JFF, Omar O, Li E, Venn ML, Pgdme, Abou Chaar MK, Capizzi V, Chaudhry D, Desai A, Edwards JG, Evans JP, Fiore M, Videria JF, Ford SJ, Ganly I, Griffiths EA, Gujjuri RR, Kolias AG, Kaafarani HMA, Minaya-Bravo A, McKay SC, Mohan HM, Roberts KJ, San Miguel-Méndez C, Pockney P, Shaw R, Smart NJ, Stewart GD, Sundar Mrcog S, Vidya R, Bhangu AA; COVIDSurg Collaborative. J Clin Oncol. 2021 Jan 1;39(1):66-78. doi: 10.1200/JCO.20.01933. Epub 2020 Oct 6. PMID: 33021869

Delaying surgery for patients with a previous SARS-CoV-2 infection.

COVIDSurg Collaborative. Br J Surg. 2020 Nov;107(12):e601-e602. doi: 10.1002/bjs.12050. Epub 2020 Sep 25. PMID: 32974904

Robot-assisted kidney transplantation: update from the European Robotic Urology Section (ERUS) series.

Musquera M, Peri L, Ajami T, Campi R, Tugcu V, Decaestecker K, Stockle M, Fornara P, Doumerc N, Vigues F, Barod R, Desender L, Territo A, Serni S, Vignolini G, Sahin S, Zeuschner P, Banga N, Breda A, Alcaraz A. BJU Int. 2021 Feb;127(2):222-228. doi: 10.1111/bju.15199. Epub 2020 Sep 29. PMID: 32770633

Safety and feasibility of early single-dose mitomycin C bladder instillation after robot-assisted radical nephroureterectomy.

Gulamhusein A, Silva P, Cullen D, Tran M, Mumtaz F, Patki P, Barod R, Bex A. BJU Int. 2020 Dec;126(6):739-744. doi: 10.1111/bju.15162. Epub 2020 Aug 9. PMID: 32638490

Guideline adherence for the surgical treatment of T1 renal tumours correlates with hospital volume: an analysis from the British Association of Urological Surgeons Nephrectomy Audit.

Tran MGB, Aben KKH, Werkhoven E, Neves JB, Fowler S, Sullivan M, Stewart GD, Challacombe B, Mahrous A, Patki P, Mumtaz F, Barod R, Bex A; British Association of Urological Surgeons. BJU Int. 2020 Jan;125(1):73-81. doi: 10.1111/bju.14862. Epub 2019 Aug 18.PMID: 31293036

Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing NEphron Sparing Treatment (NEST) for small renal masses.

Neves JB, Cullen D, Grant L, Walkden M, Bandula S, Patki P, Barod R, Mumtaz F, Aitchison M, Pizzo E, Ranieri V, Williams N, Wildgoose W, Gurusamy K, Emberton M, Bex A, Tran MGB. BMJ Open. 2019 Jun 11;9(6):e030965. doi: 10.1136/bmjopen-2019-030965.PMID: 31189686

Comprehensive training in robotic surgery.

Brook NR, Dell’Oglio P, Barod R, Collins J, Mottrie A. Curr Opin Urol. 2019 Jan;29(1):1-9. doi: 10.1097/MOU.0000000000000566.PMID: 30394945

Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior.

Jamal M, Taneja K, Arora S, Barod R, Rogers CG, Sanchez J, Gupta NS, Williamson SR. Int J Surg Pathol. 2018 Sep;26(6):536-541. doi: 10.1177/1066896918763948. Epub 2018 Mar 21.PMID: 29560759

Contemporary surgical management of renal oncocytoma: a nation’s outcome.

Neves JB, Withington J, Fowler S, Patki P, Barod R, Mumtaz F, O’Brien T, Aitchison M, Bex A, Tran MGB; British Association of Urological Surgeons (BAUS). BJU Int. 2018 Jun;121(6):893-899. doi: 10.1111/bju.14159. Epub 2018 Mar 2.PMID: 29397002

Initial robotic assistance in the surgical management of renal cell carcinoma with level 4 cavoatrial thrombus.

Palma-Zamora I, Dalela D, Barod R, Hsu L, Menon M, Rogers CG. J Robot Surg. 2018 Dec;12(4):737-740. doi: 10.1007/s11701-017-0766-1. Epub 2017 Dec 4.PMID: 29204888

Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.

Favazza L, Chitale DA, Barod R, Rogers CG, Kalyana-Sundaram S, Palanisamy N, Gupta NS, Williamson SR.

Mod Pathol. 2017 Nov;30(11):1603-1612. doi: 10.1038/modpathol.2017.72. Epub 2017 Jul 21.PMID: 28731045

Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass.

Withington J, Neves JB, Barod R. Curr Urol Rep. 2017 Aug;18(8):61. doi: 10.1007/s11934-017-0705-8.PMID: 28664237

Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.

Williamson SR, Gadde R, Trpkov K, Hirsch MS, Srigley JR, Reuter VE, Cheng L, Kunju LP, Barod R, Rogers CG, Delahunt B, Hes O, Eble JN, Zhou M, McKenney JK, Martignoni G, Fleming S, Grignon DJ, Moch H, Gupta NS. Hum Pathol. 2017 May;63:149-156. doi: 10.1016/j.humpath.2017.03.004. Epub 2017 Mar 14.PMID: 28315424

Use of Main Renal Artery Clamping Predominates Over Minimal Clamping Techniques During Robotic Partial Nephrectomy for Complex Tumors.

Lieberman L, Barod R, Dalela D, Diaz-Insua M, Abaza R, Adshead J, Ahlawat R, Challacombe B, Dasgupta P, Gandaglia G, Moon DA, Novara G, Porpiglia F, Mottrie A, Bhandari M, Rogers C. J Endourol. 2017 Feb;31(2):149-152. doi: 10.1089/end.2016.0678. Epub 2017 Jan 11.PMID: 27936928

Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery.

Abdullah N, Rahbar H, Barod R, Dalela D, Larson J, Johnson M, Mass A, Zargar H, Allaf M, Bhayani S, Stifelman M, Kaouk J, Rogers C. BJU Int. 2016 Aug;118(2):298-301. doi: 10.1111/bju.13408. Epub 2016 Feb 15.PMID: 27417163

Use of the Satinsky clamp for hilar clamping during robotic partial nephrectomy: indications, technique, and multi-center outcomes.

Abdullah N, Rahbar H, Barod R, Dalela D, Larson J, Johnson M, Mass A, Zargar H, Kaouk J, Allaf M, Bhayani S, Stifelman M, Rogers C. J Robot Surg. 2017 Mar;11(1):47-51. doi: 10.1007/s11701-016-0611-y. Epub 2016 Jun 21.PMID: 27329237

Robotic nephrectomy for central renal tumors with intraoperative evaluation of tumor histology.

Lieberman L, Barod R, Tapper A, Kumar R, Rogers C. J Robot Surg. 2016 Sep;10(3):261-5. doi: 10.1007/s11701-016-0596-6. Epub 2016 May 4.PMID: 27146858

Robotic partial nephrectomy for renal tumours in obese patients: Perioperative outcomes in a multi-institutional analysis.

Abdullah N, Dalela D, Barod R, Larson J, Johnson M, Mass A, Zargar H, Allaf M, Bhayani S, Stifelman M, Kaouk J, Rogers C. Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E859-62. doi: 10.5489/cuaj.3197. Epub 2015 Dec 14.PMID: 26788235

Robot-assisted hepatic mobilization and control of suprahepatic infradiaphragmatic inferior vena cava for level 3 vena caval thrombectomy: An IDEAL stage 0 study.

Sood A, Jeong W, Barod R, Bahnson E, Kirura P, Abdollah F, Bhandari M, Bahnson R, Menon M. J Surg Oncol. 2015 Dec;112(7):741-5. doi: 10.1002/jso.23980. Epub 2015 Aug 11.PMID: 26265131

Urinary fistula after robot-assisted partial nephrectomy: a multicentre analysis of 1 791 patients.

Potretzke AM, Knight BA, Zargar H, Kaouk JH, Barod R, Rogers CG, Mass A, Stifelman MD, Johnson MH, Allaf ME, Sherburne Figenshau R, Bhayani SB. BJU Int. 2016 Jan;117(1):131-7. doi: 10.1111/bju.13249. Epub 2015 Sep 6.PMID: 26235802

Endovascular Extraction of Caval Tumor Thrombus to Facilitate Minimally Invasive Cytoreductive Nephrectomy for Metastatic Kidney Cancer.

Rogers C, Barod R, Schwartz S, Menon M. Eur Urol. 2015 Jul;68(1):167-8. doi: 10.1016/j.eururo.2015.03.039. Epub 2015 Apr 3.PMID: 25843640

Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element.

Xu J, Wang B, Xu Y, Sun L, Tian W, Shukla D, Barod R, Grillari J, Grillari-Voglauer R, Maxwell PH, Esteban MA. Oncogene. 2012 Feb 23;31(8):1065-72. doi: 10.1038/onc.2011.305. Epub 2011 Aug 15.PMID: 21841824

Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis.

Khan MN, Bhattacharyya T, Andrikopoulos P, Esteban MA, Barod R, Connor T, Ashcroft M, Maxwell PH, Kiriakidis S. Br J Cancer. 2011 Mar 29;104(7):1151-9. doi: 10.1038/bjc.2011.73. Epub 2011 Mar 8.PMID: 21386837

A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib.

Tuthill M, Barod R, Pyle L, Cook T, Chew S, Gore M, Maxwell P, Eisen T. BMJ Case Rep. 2009;2009:bcr08.2008.0732. doi: 10.1136/bcr.08.2008.0732. Epub 2009 Feb 16.PMID: 21686655

Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin.

Harten SK, Shukla D, Barod R, Hergovich A, Balda MS, Matter K, Esteban MA, Maxwell PH. Mol Biol Cell. 2009 Feb;20(3):1089-101. doi: 10.1091/mbc.e08-06-0566. Epub 2008 Dec 10.PMID: 19073886